These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 22260386)

  • 1. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
    Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade carcinomas involving the renal sinus: report of a case and review of the differential diagnosis and immunohistochemical expression.
    Young A; Kunju LP
    Arch Pathol Lab Med; 2012 Aug; 136(8):907-10. PubMed ID: 22849739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
    Alshenawy HA
    Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.
    Albadine R; Schultz L; Illei P; Ertoy D; Hicks J; Sharma R; Epstein JI; Netto GJ
    Am J Surg Pathol; 2010 Jul; 34(7):965-9. PubMed ID: 20463571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical diagnosis of renal neoplasms.
    Truong LD; Shen SS
    Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
    Gunia S; Erbersdobler A; Koch S; Otto W; Staibano S; D'Alterio C; Brookman-May S
    Hum Pathol; 2013 May; 44(5):712-7. PubMed ID: 23158209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
    Pramick M; Ziober A; Bing Z
    Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.
    Pan Z; Grizzle W; Hameed O
    Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
    Memeo L; Jhang J; Assaad AM; McKiernan JM; Murty VV; Hibshoosh H; Tong GX; Mansukhani MM
    Am J Clin Pathol; 2007 Feb; 127(2):225-9. PubMed ID: 17210525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
    Kuroda N; Agatsuma Y; Tamura M; Martinek P; Hes O; Michal M
    Int J Clin Exp Pathol; 2015; 8(2):2131-8. PubMed ID: 25973115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic impact of p63 immunoreactivity in renal malignancies.
    Tuna B; Unlu M; Aslan G; Secil M; Yorukoglu K
    Anal Quant Cytol Histol; 2009 Apr; 31(2):118-22. PubMed ID: 19402389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary carcinoma of renal calyx.
    Williams PA; Mai KT
    Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
    He H; Zhou GX; Zhou M; Chen L
    Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.